Recently, a radiolabeled monoclonal antibody (MAb) to PSMA named J591, was used for non-invasive imaging and radiotherapy for prostate cancer in human subjects with positive results [12], [13], [14]. This evidence concerns the gene FOLH1 and prostate carcinoma.